세계 뇌 및 신경 이미징 디바이스 시장 : 이미징 유형, 절차, 용도, 최종 사용자, 지역별 분석(-2030년)

According to Stratistics MRC, the Global Brain and Neuroimaging Devices Market is accounted for $22.4 billion in 2023 and is expected to reach $36.2 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Brain and neuroimaging devices are medical devices used to capture the structure, function, or pharmacology of the brain and locate areas affected by neurological disorders. The area of medical imaging known as neuroimaging focuses on the brain. Neuroimaging investigates how the brain functions in addition to identifying diseases and evaluating brain health. Neuroscientists can view the interior of the living brain using brain imaging devices.

According to the National Institute of Health, funding for neurodegenerative diseases was US$ 4,021 million in 2020.

Market Dynamics:

Driver:

Technology advancements

Technology advancements have increased the functionality and effectiveness of brain and neuroimaging device. The ability to investigate brain anatomy and function, for instance, has improved with the introduction of high-resolution imaging techniques like functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI). Additionally, as a result of technological advancements, the market is still growing since they make it possible for scans to be completed more quickly and with more patient comfort.

Restraint:

High cost of imaging equipment

The market for brain and neuroimaging technologies is predicted to suffer from the high cost of imaging equipment. High-end equipment is needed for brain-computer interface research in cognitive psychology and neurology, including functional magnetic resonance imaging (fMRI), positron emission tomography (PET), and electroencephalography (EEG). However, these are expensive devices that not all hospitals and laboratories, particularly in developing nations, can afford. Therefore, the high cost of imaging systems, which limits the purchasing power of hospitals and diagnostic labs, is a barrier to the market for brain and neuroimaging devices.

Opportunity:

Personalized medicine and precision imaging

The objective of personalised medicine is to modify medical care in accordance with a patient's particular traits, including their particular brain structure and function. Neuroimaging technology can be quite useful in delivering individualised information for better treatment planning and neurological condition monitoring. Furthermore, in order to find patient-specific biomarkers and improve treatment outcomes, precision imaging approaches, including functional connectivity mapping and multimodal imaging integration, are being developed, which expands the market.

Threat:

Regulatory challenges

The market for brain and neuroimaging devices is subject to strict rules and authorization from regulatory agencies, including the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). Additionally, it might take time and money to obtain regulatory clearance or approval for new imaging technologies or devices. Companies in this area face difficulties adhering to evolving regulatory norms and criteria. These regulatory challenges hinder market growth.

COVID-19 Impact

The COVID-19 epidemic has had a wide range of effects on the market and the field of neuroimaging devices. The use of neuroimaging tools like MRI and CT scans in clinical settings increased as medical practitioners sought to comprehend exactly the virus affected the brain and the associated neurological symptoms. The demand for these gadgets and associated technologies increased as a result. The epidemic delayed the production and distribution of medical equipment, especially neuroimaging devices, and interrupted supply networks.

The ambulatory surgical centers segment is expected to be the largest during the forecast period

The ambulatory surgical centers segment is estimated to hold the largest share. In the market for brain and neuroimaging devices, the Ambulatory Surgical Centres (ASCs) segment is particularly important for the diagnosis and management of neurological diseases. These facilities frequently act as outpatient settings for a variety of medical interventions, such as neurosurgery and interventional radiological procedures, where neuroimaging technologies are crucial instruments. Neuroimaging equipment will continue to be crucial to the diagnostic and therapeutic pathways within ASCs as healthcare systems prioritise outpatient care and minimally invasive procedures.

The cerebral oximeters segment is expected to have the highest CAGR during the forecast period

The cerebral oximeters segment is anticipated to have lucrative growth during the forecast period. The Cerebral Oximeters, which specialises in measuring and evaluating cerebral oxygenation levels, is an essential part of the brain and neuroimaging devices industry. These tools, including near-infrared spectroscopy (NIRS) systems, are essential for non-invasively detecting the oxygen saturation levels in the brain's tissues and delivering significant information for evaluating cerebral health. In a variety of medical settings, such as operating rooms, neonatal care units, and research labs, these devices are increasingly used because they provide insightful information on brain health.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period due to advanced healthcare infrastructure, substantial R&D investments, and a high prevalence of neurological disorders. With a vast network of hospitals, clinics, and research facilities, North America has one of the most sophisticated healthcare infrastructures in the world. This infrastructure makes it easier to acquire and use neuroimaging technology for both research and clinical diagnosis. Numerous neurological injuries, multiple sclerosis, Alzheimer's disease, Parkinson's disease, and other conditions are relatively common in this region.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period. Europe is characterised by a strong healthcare system, cutting-edge medical technology, and a rising interest in neurological illnesses. A network of contemporary hospitals, clinics, and research facilities is part of Europe's established and extensive healthcare infrastructure. This infrastructure encourages the adoption and use of neuroimaging technology for clinical diagnosis and academic study. For early diagnosis, disease monitoring, and research, this high disease prevalence increases the need for improved neuroimaging technologies. Neuroimaging methods are more widely available to patients and medical professionals in many European nations thanks to favourable payment regulations.

Key players in the market:

Some of the key players in the Brain and Neuroimaging Devices Market include: Canon, Hitachi Medical Systems, General Electric Company, Philips, Varian Medical Systems, Siemens, Toshiba Medical Systems, NeuroSoft, Sanrad Medical Systems Pvt. Ltd, Esaote SpA, Medtronic Plc, Elekta AB, Natus Medical Incorporated, Magstim Company Ltd., Compumedics Limited and Brainlab AG.

Key Developments:

In August 2022, Siemens Smart Infrastructure (SI), the market leader in digital buildings, completed the acquisition of Brightly Software, a leading asset and maintenance management software-as-a-service (SaaS) provider based in the United States. The acquisition propels SI to the forefront of the software market for buildings and built infrastructure.

In April 2022, Varian, a Siemens Healthineers company, announced a five-year research and professional services agreement with Icon Group (Icon). Icon may participate in clinical and technical research programs, product evaluation projects, and consultations with Varian under this agreement to provide clinical expertise and industry perspectives throughout product development.

Imaging Types Covered:

• Computed Tomography
• Functional Magnetic Resonance Imaging
• Positron Emission Tomography
• Electroencephalography
• Near Infrared Spectroscopy
• Magneto encephalography
• Intracranial Pressure Monitors
• Cerebral Oximeters
• Sleep Monitoring Devices
• Electromyography Devices
• Other Imaging Types

Procedures Covered:

• Invasive
• Non-Invasive

Applications Covered:

• Traumatic Brain Injury
• Dementia
• Parkinson's Disease
• Sleep Disorders
• Epilepsy
• Huntington's Disease
• Headache Disorders
• Other Applications

End Users Covered:

• Ambulatory Surgical Centers
• Diagnostic Centers
• Hospitals
• Clinics

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Brain and Neuroimaging Devices Market, By Imaging Type

• 5.1 Introduction
• 5.2 Computed Tomography
• 5.3 Functional Magnetic Resonance Imaging
• 5.4 Positron Emission Tomography
• 5.5 Electroencephalography
• 5.6 Near Infrared Spectroscopy
• 5.7 Magnetoencephalography
• 5.8 Intracranial Pressure Monitors
• 5.9 Cerebral Oximeters
• 5.10 Sleep Monitoring Devices
• 5.11 Electromyography Devices
• 5.12 Other Imaging Types

6 Global Brain and Neuroimaging Devices Market, By Procedure

• 6.1 Introduction
• 6.2 Invasive
• 6.3 Non-Invasive

7 Global Brain and Neuroimaging Devices Market, By Application

• 7.1 Introduction
• 7.2 Traumatic Brain Injury
• 7.3 Dementia
• 7.4 Parkinson's Disease
• 7.5 Sleep Disorders
• 7.6 Epilepsy
• 7.7 Huntington's Disease
• 7.8 Headache Disorders
• 7.9 Other Applications

8 Global Brain and Neuroimaging Devices Market, By End User

• 8.1 Introduction
• 8.2 Ambulatory Surgical Centers
• 8.3 Diagnostic Centers
• 8.4 Hospitals
• 8.5 Clinics

9 Global Brain and Neuroimaging Devices Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Canon
• 11.2 Hitachi Medical Systems
• 11.3 General Electric Company
• 11.4 Philips
• 11.5 Varian Medical Systems
• 11.6 Siemens
• 11.7 Toshiba Medical Systems
• 11.8 NeuroSoft
• 11.9 Sanrad Medical Systems Pvt. Ltd
• 11.10 Esaote SpA
• 11.11 Medtronic Plc
• 11.12 Elekta AB
• 11.13 Natus Medical Incorporated
• 11.14 Magstim Company Ltd.
• 11.15 Compumedics Limited
• 11.16 Brainlab AG